Ulcers and Gastritis

This article reviews recently published reports on ulcers and gastritis. Helicobacter pylori is known to be an important pathogen involved in gastroduodenal inflammation and peptic ulcers. Conventional endoscopy is of limited usefulness in the evaluation of gastritis, but magnifying endoscopy is evidently helpful in the diagnosis of chronic atrophic gastritis, intestinal metaplasia, and H. pylori infection. A significant reduction in the incidence of refractory ulcers and the prevalence of H. pylori infection in patients with peptic ulcer disease followed the introduction of H. pylori eradication treatment. Chronic H. pylori infection is associated with gastric cancer, and the effect of H. pylori eradication on the prevention of gastric cancer is an important issue that is still a matter of controversy. Endoscopic hemostasis and intravenous proton-pump inhibitor (PPI) infusion represent a widely accepted approach to the treatment of peptic ulcer bleeding. In clinical practice, it is important to prevent recurrent bleeding and to treat patients who do not respond to endoscopic therapy or PPI treatment. Laparoscopic repair for peptic ulcer perforations, with postoperative eradication treatment, has gradually met with acceptance in patients with H. pylori infection. H. pylori infection and its treatment continue to be interesting problems in this field.

References

• 1 Uhlig H H, Tannapfel A, Mossner J. et al . Histopathological parameters of Helicobacter pylori-associated gastritis in children and adolescents: comparison with findings in adults.  Scand J Gastroenterol. 2003;  38 701-706
• 2 Nakayama Y, Horiuchi A, Kumagai T. et al . Discrimination of normal gastric mucosa from Helicobacter pylori gastritis using standard endoscopes and a single observation site: studies in children and young adults.  Helicobacter. 2004;  9 95-99
• 3 Redeen S, Petersson F, Jonsson K A. et al . Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample.  Endoscopy. 2003;  35 946-950
• 4 Yang J M, Chen L, Fan Y L. et al . Endoscopic patterns of gastric mucosa and its clinicopathological significance.  World J Gastroenterol. 2003;  9 2552-2556
• 5 Nakagawa S, Kato M, Shimizu Y. et al . Relationship between histopathologic gastritis and mucosal microvascularity: observations with magnifying endoscopy.  Gastrointest Endosc. 2003;  58 71-75
• 6 Kim S, Harum K, Ito M. et al . Magnifying gastroendoscopy for diagnosis of histologic gastritis in the gastric antrum.  Dig Liver Dis. 2004;  36 286-291
• 7 Mitani K, Tatsuta M, Iishi H. et al . Helicobacter pylori infection as a risk factor for gastric ulceration.  Hepatogastroenterology. 2004;  51 309-312
• 8 Karita M, Noriyasu A, Kosako E. et al . Relationship between pepsinogen I & II and H. pylori infection considered with grade of atrophy and gastroduodenal diseases.  Dig Dis Sci. 2003;  48 1839-1845
• 9 Chiu H M, Wu M S, Hung C C. et al . Low prevalence of Helicobacter pylori but high prevalence of cytomegalovirus-associated peptic ulcer disease in AIDS patients: comparative study of symptomatic subjects evaluated by endoscopy and CD4 counts.  J Gastroenterol Hepatol. 2004;  19 423-428
• 10 Konturek S J, Bielanski W, Plonka M. et al . Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers.  Scand J Gastroenterol. 2003;  38 923-930
• 11 Kalaghchi B, Mekasha G, Jack M A. et al . Ideology of Helicobacter pylori prevalence in peptic ulcer disease in an inner-city minority population.  J Clin Gastroenterol. 2004;  38 248-251
• 12 Park J H, Kim S Y, Kim D W. et al . Correlation between Helicobacter pylori infection and vitamin C levels in whole blood, plasma, and gastric juice, and the pH of gastric juice in Korean children.  J Pediatr Gastroenterol Nutr. 2003;  37 53-62
• 13 Capurso G, Ricci R, Panzuto F. et al . Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis.  Helicobacter. 2003;  8 300-306
• 14 Kodama K, Sumii K, Kawano M. et al . Gastric juice nitrite and vitamin C in patients with gastric cancer and atrophic gastritis: is low acidity solely responsible for cancer risk?.  Eur J Gastroenterol Hepatol. 2003;  15 987-993
• 15 Matsuhisa T, Matsukura N, Yamada N. Topography of chronic active gastritis in Helicobacter pylori-positive Asian populations: age-, gender-, and endoscopic diagnosis-matched study.  J Gastroenterol. 2004;  39 324-328
• 16 Guarner J, Bartlett J, Whistler T. et al . Can pre-neoplastic lesions be detected in gastric biopsies of children with Helicobacter pylori infection?.  J Pediatr Gastroenterol Nutr. 2003;  37 309-314
• 17 Giuliani A, Spada S, Corona M. et al . Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.  J Exp Clin Cancer Res. 2003;  22 371-378
• 18 Hamaguchi K, Ogawa K, Katsube T. et al . Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.  Langenbecks Arch Surg. 2004;  389 83-91
• 19 Ley C, Mohar A, Guarner J. et al . Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial.  Cancer Epidemiol Biomarkers Prev. 2004;  13 4-10
• 20 Wong B CY, Lam S K, Wong W M. et al . Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.  JAMA. 2004;  291 187-194
• 21 Sheu B S, Yang H B, Sheu S M. et al . Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.  Clin Cancer Res. 2003;  9 5245-5251
• 22 Bardhan K D, Nayyar A K, Royston C. History in our lifetime: the changing nature of refractory duodenal ulcer in the era of histamine H2 receptor antagonists.  Dig Liver Dis. 2003;  35 529-536
• 23 Lee S K, Lee Y C, Chung J B. et al . Low grade gastric mucosa associated lymphoid tissue lymphoma: treatment strategies based on 10 year follow-up.  World J Gastroenterol. 2004;  10 223-226
• 24 Kamada T, Haruma K, Hata J. et al . The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.  Aliment Pharmacol Ther. 2003;  18 245-252
• 25 Chang C C, Pan S, Chen S H. et al . Development of multifocal duodenal erosions after anti-Helicobacter pylori triple therapy.  J Formos Med Assoc. 2003;  102 840-844
• 26 Kupcinskas L, Jonaitis L, Kiudelis G. A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease.  Eur J Gastroenterol Hepatol. 2004;  16 369-374
• 27 Kuipers E J, Nelis G F, Klinkenberg-Knol E C. et al . Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long-term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.  Gut. 2004;  53 12-20
• 28 Vaira D, Vakil N, Rugge M. et al . Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects.  Gut. 2003;  52 1543-1547
• 29 Sasaki A, Haruma K, Manabe N. et al . Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy.  Aliment Pharmacol Ther. 2003;  17 1529-1534
• 30 Hawkey C J, Laine L, Simon T. et al . Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study.  Gut. 2003;  52 820-826
• 31 Pavelka K, Recker D P, Verburg K M. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial.  Rheumatology (Oxford). 2003;  42 1207-1215
• 32 Hunt R H, Harper S, Watson D J. et al . The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.  Am J Gastroenterol. 2003;  98 1725-1733
• 33 Bias P, Buchner A, Klesser B. et al . The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial.  Am J Gastroenterol. 2004;  99 611-618
• 34 Lai K C, Lam S K, Chu K M. et al . Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users: a randomized trial.  Aliment Pharmacol Ther. 2003;  18 829-836
• 35 Lopez Vallejos  P, Garcia Sanchez  MV, Gonzalez Galilea  A. et al . Failure of endoscopic therapy in upper gastrointestinal hemorrhage due to duodenal ulcers.  Rev Esp Enferm Dig. 2003;  95 700-706
• 36 Chiu P W, Lam C Y, Lee S W. et al . Effect of scheduled second therapeutic endoscopy on peptic ulcer rebleeding: a prospective randomised trial.  Gut. 2003;  52 1403-1407
• 37 Hsieh Y H, Lin H J, Tseng G Y. et al . Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.  Hepatogastroenterology. 2004;  51 316-319
• 38 Cheng H C, Chuang S A, Kao Y H. et al . Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion.  Hepatogastroenterology. 2003;  50 2270-2273
• 39 van Rensburg C J, Hartmann M, Thorpe A. et al . Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer.  Am J Gastroenterol. 2003;  98 2635-2641
• 40 Ripoll C, Banares R, Beceiro I. et al . Comparison of transcatheter arterial embolization and surgery for treatment of bleeding peptic ulcer after endoscopic treatment failure.  J Vasc Interv Radiol. 2004;  15 447-450
• 41 Camprodon R A, Al-Ghnaniem R, Camprodon R. Transgastric surgery for posterior juxtacardial ulcers: a minimal and safe approach.  Arch Surg. 2003;  138 757-761
• 42 Siu W T, Chau C H, Law B K. et al . Routine use of laparoscopic repair for perforated peptic ulcer.  Br J Surg. 2004;  91 481-484
• 43 Seelig M H, Seelig S K, Behr C. et al . Comparison between open and laparoscopic technique in the management of perforated gastroduodenal ulcers.  J Clin Gastroenterol. 2003;  37 226-229
• 44 Siu W T, Chau C H, Law B K. et al . Therapeutic minilaparoscopy for perforated peptic ulcer.  J Laparoendosc Adv Surg Tech A. 2004;  14 51-56
• 45 Malkov I S, Zaynutdinov A M, Veliyev N A. et al . Laparoscopic and endoscopic management of perforated duodenal ulcers.  J Am Coll Surg. 2004;  198 352-355
• 46 Lee K H, Chang H C, Lo C J. Endoscope-assisted laparoscopic repair of perforated peptic ulcers.  Am Surg. 2004;  70 352-356
• 47 Lin C L, Yeh Y H, Yang C C. Panendoscopic finding of perforated peptic ulcer (PPU).  Hepatogastroenterology. 2003;  50 957-960
• 48 Gisbert J P, Legido J, Garcia-Sanz I. et al . Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.  Dig Liver Dis. 2004;  36 116-120
• 49 Datsis A C, Rogdakis A, Kekelos S. et al . Simple closure of chronic duodenal ulcer perforation in the era of Helicobacter pylori: an old procedure, today’s solution.  Hepatogastroenterology. 2003;  50 1396-1398
• 50 Kochhar R, Sethy P K, Nagi B. et al . Endoscopic balloon dilatation of benign gastric outlet obstruction.  J Gastroenterol Hepatol. 2004;  19 418-422
• 51 Nahon S, Lahmek P, Massard J. et al . Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: a reliable association?.  Helicobacter. 2003;  8 573-577
• 52 Hacihanefioglu A, Edebali F, Celebi A. et al . Improvement of complete blood count in patients with iron deficiency anemia and Helicobacter pylori infection after the eradication of Helicobacter pylori. .  Hepatogastroenterology. 2004;  51 313-315
• 53 Sotoudehmanesh R, Ali A sgari, Ansari R, Nouraie M. Endoscopic findings in end-stage renal disease.  Endoscopy. 2003;  35 502-505
• 54 Tsukada K, Miyazaki T, Katoh H. et al . Helicobacter pylori infection in hemodialysis patients.  Hepatogastroenterology. 2003;  50 2255-2258
• 55 Tsukada K, Hasegawa T, Miyazaki T. et al . Predictive value of uric acid in gastric mucosal damage in hemodialysis patients.  Hepatogastroenterology. 2003;  50 1708-1711
• 56 Liutu M, Kalimo K, Kalimo H. et al . Mast cells and IgE-containing cells in gastric mucosa of Helicobacter pylori infected and non-infected patients with chronic urticaria.  J Eur Acad Dermatol Venereol. 2004;  18 69-72
• 57 Bakos N, Fekete B, Prohaszka Z. et al . High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria.  Allergy. 2003;  58 663-667